Understanding the Treatment Benefits of Potassium Channel Activator BHV-7000: Irfan Qureshi, MD
December 12th 2023The chief medical officer at Biohaven provided clinical insight on the mechanism of action of BHV-7000, an antiseizure medication, and its supportive phase 1 data. [WATCH TIME: 4 minutes]